Synthesis of (3S, 4S)-4-hydroxy-2, 3, 4, 5-tetrahydropyridazine-3-carboxylic acid, component of luzopeptin A.
摘要:
The enantioselective synthesis of (3S, 4S)4-hydroxy-2, 3, 4, 5-tetrahydropyridazine-3-carboxylic acid 1 is described. The two stereogenic centers in anti relationship are obtained by sequential enantio and chemoselective hydrogenation of beta-ketoester in presence of chiral ruthenium catalyst and diastereoselective amination of beta-hydroxyester with di t-butylazodicarboxylate.
Synthesis of (3S, 4S)-4-hydroxy-2, 3, 4, 5-tetrahydropyridazine-3-carboxylic acid, component of luzopeptin A.
摘要:
The enantioselective synthesis of (3S, 4S)4-hydroxy-2, 3, 4, 5-tetrahydropyridazine-3-carboxylic acid 1 is described. The two stereogenic centers in anti relationship are obtained by sequential enantio and chemoselective hydrogenation of beta-ketoester in presence of chiral ruthenium catalyst and diastereoselective amination of beta-hydroxyester with di t-butylazodicarboxylate.
A general preparation of chiral ruthenium(II) catalysts and the homogeneous enantioselective hydrogenation of prochiral olefins and keto groups are presented. Some applications to the synthesis of biologically active compounds are reported. (C) 1998 Elsevier Science S.A. All rights reserved.
Synthesis of (3S, 4S)-4-hydroxy-2, 3, 4, 5-tetrahydropyridazine-3-carboxylic acid, component of luzopeptin A.
作者:Christine Greck、Laurent Bischoff、Jean Pierre Genêt
DOI:10.1016/0957-4166(95)00258-q
日期:1995.8
The enantioselective synthesis of (3S, 4S)4-hydroxy-2, 3, 4, 5-tetrahydropyridazine-3-carboxylic acid 1 is described. The two stereogenic centers in anti relationship are obtained by sequential enantio and chemoselective hydrogenation of beta-ketoester in presence of chiral ruthenium catalyst and diastereoselective amination of beta-hydroxyester with di t-butylazodicarboxylate.